Oryzon a Biopharmaceutical company dedicated to the discovery of biomarkers and development of novel therapeutics and diagnostics announced today that Dr. Tamara Maes, will present at the 4th Annual...
(PRWeb January 27, 2012)
Read the full story at http://www.prweb.com/releases/2012/1/prweb9137602.htm
Oryzon a Biopharmaceutical company dedicated to the discovery of biomarkers and development of novel therapeutics and diagnostics announced today that Dr. Tamara Maes, will present at the 4th Annual...
(PRWeb January 27, 2012)
Read the full story at http://www.prweb.com/releases/2012/1/prweb9137602.htm
Comments on this entry are closed.
Yali Friedman lives in Washington, DC and is author of Building Biotechnology and other books; founder of DrugPatentWatch; and chief editor of the Journal of Commercial Biotechnology.
Comments on this entry are closed.